Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HECB1502201 injection versus esomeprazole sodium injection for bleeding peptic ulcer
CTR20242400Phase 3Completed
- Sponsor
- HEC Pharm
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HECB1502201 in Peptic ulcer disease (PUD), sponsored by HEC Pharm. Started Jul 2024; status: completed.
02
Drugs
HECB1502201
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20242400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242400.